Clinical Trial Update: Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating TNF-α blockade for psoriatic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• TNF inhibitors

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Psoriatic Arthritis | Phase 4 | Status: COMPLETED